COVID-19 Vaccination in Iceland: Deal Signed with CureVac, Additional Pfizer Doses on the Way Skip to content
Ásta Valdimarsdóttir Health Ministry
Photo: Stjórnarráðið. Health Ministry Secretary Ásta Valdimarsdóttir signing the CureVac contract.

COVID-19 Vaccination in Iceland: Deal Signed with CureVac, Additional Pfizer Doses on the Way

Icelandic authorities have signed a contract with German manufacturer CureVac to purchase COVID-19 vaccines for 90,000 people. The vaccine is currently in Phase III trials and distribution is expected to begin in the second quarter of this year. The CureVac vaccine is an mRNA vaccine, like the Pfizer and Moderna COVID vaccines, meaning it uses a part of the virus’ genetic material to elicit antibody responses in those who are vaccinated. It requires two doses to achieve full efficacy.

Read More: What is the status of COVID-19 vaccination in Iceland?

Iceland received its first doses of COVID-19 vaccine on December 28, 2020, and began inoculating residents the following day, starting with frontline workers and nursing home residents. As of February 3, 7,245 locals have received their first dose of COVID-19 vaccine in Iceland and 4,853 have completed vaccination (roughly 3.28% of the population). Of those 90 years of age or older, 80% have received one or both doses of COVID-19 vaccine.

Iceland’s government has ensured it will receive more than enough doses of COVID-19 vaccine for the entire population, though distribution schedules for most manufacturers remain unclear. Yesterday, Iceland’s Chief Epidemiologist told RÚV that the country would be receiving 7,000 doses of the Pfizer vaccine in the next two weeks, 2,000 more than expected. Authorities have stated they aim to vaccinate the majority of the population by mid-2021.

 

Sign up for our weekly newsletter

Get news from Iceland, photos, and in-depth stories delivered to your inbox every week!

* indicates required

Subscribe to Iceland Review

In-depth stories and high-quality photography showcasing life in Iceland!

Share article

Facebook
Twitter